The Peptide Synthesis/Antibody Production Core is one of the more recent additions to the DERC Support Facilities, funding being initiated on 3/1/92. This support service represents an expansion of a previously existing peptide synthesis unit which was created in 1986 by the Scientific Council at UMMC. Our goal has been to provide consultation and reliable, affordable services in the general areas of peptide synthesis, protein isolation and antibody production in an effort to enhance diabetes and endocrine work. Over the 9 months since its inception, this HPLC purifications, 55 amino acid analyses, 22 peptide conjugations and 47 antibody productions. By providing consultation and service in these areas at subsidized rates, we have greatly enhanced the potential for good research by each DERC investigator. Solid phase Merrified synthesis is performed using FAST-Moc chemistry on a scale of 0.2 mmol (200 mg for a 10 mer). This method permits cleavage from the resin-support by brief exposure to a mild acid, resulting in a cleaner product in a shorter time. The peptide is usually subjected to HPLC-purification and amino acid analysis is used for quantitation and to assay purity. Large-scale purifications of synthesized peptides (50- 200 mg) are performed using a 100 ml column of mu-Bondapak C-18 and a linear gradient in acetonitrile (2 hours/run). Pico-Tag analyses are performed by reverse-phase HPLC and pre-column derivatization using phenyl isothiocyanate. A synthetic peptides or other haptens are coupled to carrier molecules via NH2-, COOH, SH-or tyrosyl groups. These reactions can be designed so as to orient the hapten and direct antibody specificity.

Project Start
1999-12-01
Project End
2000-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
16
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Type
DUNS #
660735098
City
Worcester
State
MA
Country
United States
Zip Code
01655
Desai, Paurav B; San Agustin, Jovenal T; Stuck, Michael W et al. (2018) Ift25 is not a cystic kidney disease gene but is required for early steps of kidney development. Mech Dev 151:10-17
Ly, Socheata; Navaroli, Deanna M; Didiot, Marie-Cécile et al. (2017) Visualization of self-delivering hydrophobically modified siRNA cellular internalization. Nucleic Acids Res 45:15-25
Wang, Feng; McCannell, Kurtis N; Boškovi?, Ana et al. (2017) Rlim-Dependent and -Independent Pathways for X Chromosome Inactivation in Female ESCs. Cell Rep 21:3691-3699
Watkin, Levi B; Mishra, Rabinarayan; Gil, Anna et al. (2017) Unique influenza A cross-reactive memory CD8 T-cell receptor repertoire has a potential to protect against EBV seroconversion. J Allergy Clin Immunol 140:1206-1210
LeBlanc, Scott E; Wu, Qiong; Lamba, Pallavi et al. (2016) Promoter-enhancer looping at the PPAR?2 locus during adipogenic differentiation requires the Prmt5 methyltransferase. Nucleic Acids Res 44:5133-47
Wang, Feng; Shin, JongDae; Shea, Jeremy M et al. (2016) Regulation of X-linked gene expression during early mouse development by Rlim. Elife 5:
Kincaid, Eleanor Z; Murata, Shigeo; Tanaka, Keiji et al. (2016) Specialized proteasome subunits have an essential role in the thymic selection of CD8(+) T cells. Nat Immunol 17:938-45
Townsley, E; O'Connor, G; Cosgrove, C et al. (2016) Interaction of a dengue virus NS1-derived peptide with the inhibitory receptor KIR3DL1 on natural killer cells. Clin Exp Immunol 183:419-30
Wyss, Lena; Stadinski, Brian D; King, Carolyn G et al. (2016) Affinity for self antigen selects Treg cells with distinct functional properties. Nat Immunol 17:1093-101
Delong, Thomas; Wiles, Timothy A; Baker, Rocky L et al. (2016) Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion. Science 351:711-4

Showing the most recent 10 out of 707 publications